Events

Retiro De Equipo (Recall) de LINX Reflux Management System

Según U.S. Food and Drug Administration, este evento ( retiro de equipo (recall) ) involucró a un dispositivo médico en United States que fue producido por Torax Medical, Inc..

¿Qué es esto?

Una corrección al equipo o acción de retiro tomada por el fabricante para abordar un problema con un dispositivo médico. Los retiros (recalls) ocurren cuando un dispositivo médico está defectuoso, cuando puede poner en riesgo la salud, o cuando simultáneamente está defectuoso y puede poner en riesgo la salud.

Más información acerca de la data acá
  • Tipo de evento
    Recall
  • ID del evento
    79822
  • Clase de Riesgo del Evento
    Class 2
  • Número del evento
    Z-2038-2018
  • Fecha de inicio del evento
    2018-04-20
  • Estado del evento
    Open, Classified
  • País del evento
    United States
  • Fuente del evento
    USFDA
  • URL de la fuente del evento
    https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfres/res.cfm?id=163589
  • Notas / Alertas
    U.S. data is current through June 2018. All of the data comes from the U.S. Food and Drug Administration, except for the category Manufacturer Parent Company.
    The Parent Company was added by ICIJ.
    The parent company information is based on 2017 public records.
  • Notas adicionales en la data
    Implant, anti-gastroesophageal reflux - Product Code LEI
  • Causa
    Possible out of specification condition which may allow a bead component to separate from an adjacent wire link. this condition may result in a discontinuous or open linx device.
  • Acción
    The firm, Consignees Torax Medical Inc., sent an "URGENT: FIELD SAFETY NOTICE (REMOVAL)" letter mailed on approximately 04/20/2018 (US consignees and physicians) and 04/23/2018 (OUS consignees and physicians). The letter described the product, problem and actions to be taken. The customers were instructed to examine inventory for affected product, quarantine any affected product, communicate the issue to all relevant operating room or materials management personnel, forward the recall information to facilities where the product may have been forwarded to, complete the Business Reply Form confirming receipt of this notice and return it to Torax Medical, Inc. within three (3) business days via email at brf@toraxmedical.com; ( return the BRF even if you do not have the product lot subject to this recall.), and arrange the return of any affected product on hand. Additionally, a recall notification will be sent to sent to physicians outlining the reason for recall and to advise them to monitor their patients. Question regarding the recall can be directed to the Customer Support Cetner at 1-877-384-4266, which is open Monday through Friday, 7:30 AM to 6:30 PM ET.

Device

LINX Reflux Management System
  • Modelo / Serial
    a. Product Code LXC-12, Part No. 3718-12, GTIN 00855106005134;  b. Product Code LXC-13, Part No. 3718-13, GTIN 00855106005141;  c. Product Code LXC-14, Part No. 3718-14, GTIN 00855106005158;  d. Product Code LXC-15, Part No. 3718-15, GTIN 00855106005165;  e. Product Code LXC-16, Part No. 3718-16, GTIN 00855106005172;  f. Product Code LXC-17, Part No. 3718-17, GTIN 00855106005189;   Lot No. 6100 through 14055, 15286, 15287, 15314, 15315, 15317, and 16557
  • Clasificación del producto
    Gastroenterology-Urology Devices
  • Clase de dispositivo
    3
  • ¿Implante?
    Yes
  • Distribución
    Worldwide Distribution: US (nationwide) in states of: AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, WA, WI, WV, WY; and in countries of: Austria, France, Germany, Italy, Scotland, Spain, Switzerland, United Kingdom.
  • Descripción del producto
    LINX Reflux Management System, Implant Clasp, 12-17 Bead, 0.7T, Product Code LXC-xx, sterile, Rx only. Labeled as: || a. Product Code LXC-12; || b. Product Code LXC-13; || c. Product Code LXC-14; || d. Product Code LXC-15; || e. Product Code LXC-16; || f. Product Code LXC-17; || Laparoscopic, fundic-sparing anti-reflux procedure indicated for patients diagnosed with Gastroesophageal Reflux Disease (GERD) as defined by abnormal pH testing, and who are seeking an alternative to continuous acid suppression therapy (i.e. proton pump inhibitors or equivalent) in the management of their GERD.
  • Manufacturer
    Torax Medical, Inc.

Manufacturer

Torax Medical, Inc.
  • Dirección del fabricante
    Torax Medical, Inc., 4188 Lexington Ave N, Shoreview MN 55126-6106
  • Empresa matriz del fabricante (2017)
    Johnson & Johnson
  • Source
    USFDA